中文名称：N-（2,6-二甲基苯基）-1-甲基哌啶-2-甲酰胺
  • (-）-1-甲基-2'，6'-哌啶; 甲皮卡伊纳; Mepivacaina [INN-西班牙语]; 哌哌卡南; 甲哌卡农 [INN-Latin]; N-甲基-2-哌啶酸，2,6-二甲基苯胺; N-甲基-2-哌啶酸，2,6-二甲苯二甲酸; N-甲基六氢-2-吡啶甲酸，2,6-二甲基苯胺; 斯堪地卡因; 斯堪替卡因; UNII-B6E06QE59J; 1-甲基-2'，6'-哌啶; N-（2,6-二甲基苯基）-1-甲基-2-哌啶甲酰胺; N-（2,6-二甲基苯基）-1-甲基哌啶-2-甲酰胺
  • N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide
  • (+-)-1-Methyl-2',6'-pipecoloxylidide; Mepivacaina; Mepivacaina [INN-Spanish]; Mepivacainum; Mepivacainum [INN-Latin]; N-Methyl-2-pipecolic acid, 2,6-dimethylanilide; N-Methyl-2-pipecolic acid, 2,6-xylidide; N-Methylhexahydro-2-picolinic acid, 2,6-dimethylanilide; Scandicain; Scandicaine; UNII-B6E06QE59J; 2',6'-Pipecoloxylidide, 1-methyl-; 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-; N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide
  • 96-88-8
  • 202-543-0
  • C15H22N2O
  • 246.3481
  • InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)
  • N-（2,6-二甲基苯基）-1-甲基哌啶-2-甲酰胺 96-88-8